Find clinical trials for Melanoma in New Haven, CT
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Melanoma trials near New Haven, CT, USA:
This is an open label study evaluating lifileucel (LN-144) in patients with metastatic uveal melanoma....
Phase 1
Harrison, New York, United States and 1 other location
Prospective, interventional multicenter study evaluating adoptive cell therapy (ACT) via infusion of LN-144 (autologous TIL) followed by interleukin...
Phase 2
New Haven, Connecticut, United States and 56 other locations
and safe treatment for people with advanced or metastatic mucosal melanoma that has not been treated before.The researchers think that a com...
Phase 2
Harrison, New York, United States and 1 other location
is to test the effects of the study drug, ensartinib, on the patient and the cancer. Ensartinib is a new, investigational type of treatment for melanoma...
Phase 2
Harrison, New York, United States and 3 other locations
administered to participants with unresectable or metastatic melanoma.The study is divided into two phases: Phase 2 and Phase 3.The primary ...
Phase 2, Phase 3
Hartford, Connecticut, United States and 19 other locations
with the standard-of-care drug combination, nivolumab and relatlimab, is a safe and effective treatment for people with untreated, unresectable melanoma...
Phase 2
Hartford, Connecticut, United States and 8 other locations
study to evaluate the efficacy, safety, and tolerability of APX005M in combination with nivolumab and ipilimumab in patients with advanced melanoma...
Phase 1
New Haven, Connecticut, United States and 1 other location
Pembrolizumab and Lenvatinib in Patients With Brain Metastases From Melanoma or Renal Cell Carcinoma
This is a phase 2, Simon's 2-stage designed study with 2 cohorts of anti-PD-1/PD-L1 experienced patients with untreated brain metastases: 1) melanoma...
Phase 2
New Haven, Connecticut, United States
and pembrolizumab improves recurrence free survival (RFS) compared to pembrolizumab alone in participants with complete resection of cutaneous melanoma...
Phase 2
New Haven, Connecticut, United States and 20 other locations
with relapsed or refractory (R/R) metastatic or locally advanced melanoma, non-small cell lung cancer (NSCLC), and colorectal cancer (CRC)....
Phase 1
New Haven, Connecticut, United States and 15 other locations
Clinical trials
Research sites
Resources
Legal